236 related articles for article (PubMed ID: 9250158)
41. Expression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and p53 tumor suppressor in dysplastic progression and adenocarcinoma in Barrett esophagus.
Hanas JS; Lerner MR; Lightfoot SA; Raczkowski C; Kastens DJ; Brackett DJ; Postier RG
Cancer; 1999 Sep; 86(5):756-63. PubMed ID: 10463972
[TBL] [Abstract][Full Text] [Related]
42. Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma.
Kitamura H; Kameda Y; Nakamura N; Nakatani Y; Inayama Y; Iida M; Noda K; Ogawa N; Shibagaki T; Kanisawa M
Am J Pathol; 1995 Apr; 146(4):876-87. PubMed ID: 7717455
[TBL] [Abstract][Full Text] [Related]
43. STAT3 activation and aberrant ligand-dependent sonic hedgehog signaling in human pulmonary adenocarcinoma.
Yang Q; Shen SS; Zhou S; Ni J; Chen D; Wang G; Li Y
Exp Mol Pathol; 2012 Oct; 93(2):227-36. PubMed ID: 22554932
[TBL] [Abstract][Full Text] [Related]
44. [Evaluation of p53, p21waf1, and PCNA in the diagnosis on lung cancer].
Ding X; Yang J; Hu S; Wu X; Li Q
Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Feb; 22(1):54-7. PubMed ID: 11860847
[TBL] [Abstract][Full Text] [Related]
45. Atypical alveolar hyperplasia: relationship with pulmonary adenocarcinoma, p53, and c-erbB-2 expression.
Kerr KM; Carey FA; King G; Lamb D
J Pathol; 1994 Dec; 174(4):249-56. PubMed ID: 7884586
[TBL] [Abstract][Full Text] [Related]
46. Expression of cyclin dependent kinase inhibitor p21waf1/cip1 in premalignant and malignant oral lesions: relationship with p53 status.
Agarwal S; Mathur M; Shukla NK; Ralhan R
Oral Oncol; 1998 Sep; 34(5):353-60. PubMed ID: 9861340
[TBL] [Abstract][Full Text] [Related]
47. Atypical adenomatous hyperplasia and adenocarcinoma of the human lung: their heterology in form and analogy in immunohistochemical characteristics.
Mori M; Tezuka F; Chiba R; Funae Y; Watanabe M; Nukiwa T; Takahashi T
Cancer; 1996 Feb; 77(4):665-74. PubMed ID: 8616758
[TBL] [Abstract][Full Text] [Related]
48. Expression of p21WAF1/CIP1 in colorectal adenomas and adenocarcinomas and its correlation with p53 protein expression.
Yasui W; Akama Y; Yokozaki H; Semba S; Kudo Y; Shimamoto F; Tahara E
Pathol Int; 1997 Jul; 47(7):470-7. PubMed ID: 9234386
[TBL] [Abstract][Full Text] [Related]
49. Clinical significance of p21 expression in non-small-cell lung cancer.
Shoji T; Tanaka F; Takata T; Yanagihara K; Otake Y; Hanaoka N; Miyahara R; Nakagawa T; Kawano Y; Ishikawa S; Katakura H; Wada H
J Clin Oncol; 2002 Sep; 20(18):3865-71. PubMed ID: 12228206
[TBL] [Abstract][Full Text] [Related]
50. Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas.
Boschman CR; Stryker S; Reddy JK; Rao MS
Am J Pathol; 1994 Dec; 145(6):1291-5. PubMed ID: 7992834
[TBL] [Abstract][Full Text] [Related]
51. [Study on the relation between the cell cycle regulators and laryngeal carcinogenesis].
Wang J; Lou W; Dong M
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Mar; 15(3):112-4. PubMed ID: 12541678
[TBL] [Abstract][Full Text] [Related]
52. p21waf1/cip1mda-6 expression in non-small-cell lung cancer: relationship to survival.
Caputi M; Esposito V; Baldi A; De Luca A; Dean C; Signoriello G; Baldi F; Giordano A
Am J Respir Cell Mol Biol; 1998 Feb; 18(2):213-7. PubMed ID: 9476908
[TBL] [Abstract][Full Text] [Related]
53. p53 protein expression in transitional mucosa and adenocarcinomas of the colorectum.
Connelly JH; Bruner JM; Robey-Cafferty SS; Sahin A
Mod Pathol; 1992 Sep; 5(5):537-9. PubMed ID: 1344817
[TBL] [Abstract][Full Text] [Related]
54. The evaluation of SOX9 expression and its relationship with carcinoembryonic antigen-related cell adhesion molecule 1 in gastric neoplastic and nonneoplastic lesions.
Liu JN; Shang Guan YM; Qi YZ; Wang HB; Zhang TG; Zhou CJ
Ann Diagn Pathol; 2012 Aug; 16(4):235-44. PubMed ID: 22209504
[TBL] [Abstract][Full Text] [Related]
55. [An early carcinoma of the gallbladder with atypical epithelium ( a report of a case with elevated p53 expression)].
Yabar HA; Watanabe H
Rev Gastroenterol Peru; 1994; 14(1):65-8. PubMed ID: 8018902
[TBL] [Abstract][Full Text] [Related]
56. Immunohistological comparison of the World Health Organization (WHO) and Ljubljana classifications on the grading of preneoplastic lesions of the larynx.
Sengiz S; Pabuççuoğlu U; Sarioğlu S
Pathol Res Pract; 2004; 200(3):181-8. PubMed ID: 15200269
[TBL] [Abstract][Full Text] [Related]
57. Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in stage I adenocarcinomas of the lung.
Xue Q; Sano T; Kashiwabara K; Saito M; Oyama T; Nakajima T
Pathol Int; 2002 Feb; 52(2):103-9. PubMed ID: 11940214
[TBL] [Abstract][Full Text] [Related]
58. Expression and significance of tumoral suppressor p53 gene in lung adenocarcinomas.
Cornianu M; Tudose N; Potencz E; Lazăr E
Rom J Morphol Embryol; 1996; 42(1-2):73-82. PubMed ID: 9038389
[TBL] [Abstract][Full Text] [Related]
59. Strong cytoplasmic expression of COX2 at the invasive fronts of gallbladder cancer is associated with a poor prognosis.
Kim H; Song JY; Cho JY; Yoon YS; Han HS; Lee HS; Ryu HS; Choe G
J Clin Pathol; 2010 Dec; 63(12):1048-53. PubMed ID: 20924037
[TBL] [Abstract][Full Text] [Related]
60. Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content.
Nakayama H; Noguchi M; Tsuchiya R; Kodama T; Shimosato Y
Mod Pathol; 1990 May; 3(3):314-20. PubMed ID: 2362938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]